CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
113 hedge funds and large institutions have $169M invested in Cymabay Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 37 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 37
48% less call options, than puts
Call options by funds: $1.41M | Put options by funds: $2.72M
Holders
113
Holding in Top 10
4
Calls
$1.41M
Puts
$2.72M
Top Buyers
| 1 | +$4.75M | |
| 2 | +$2.34M | |
| 3 | +$487K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$420K |
| 5 |
Franklin Resources
San Mateo,
California
|
+$337K |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$2.02M | |
| 3 | -$1.7M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.4M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.3M |